This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Bayer Corporation, Millennium Pharmaceuticals Limited, The University of Texas System. Active years: 2001-2010.
Location History:
- Norfolk, MA (US) (2002)
- Norwood, MA (US) (2001 - 2010)
Company Filing History:
2 out of 1,013 
2 out of 854 
2 out of 5,633 
Years Active: 2001-2010
Title: Innovations of Wilson O Endege
Introduction
Wilson O Endege is a notable inventor based in Norwood, MA (US). He has made significant contributions to the field of cancer research, holding a total of 5 patents. His work focuses on the identification, assessment, prevention, and therapy of ovarian and breast cancers.
Latest Patents
Among his latest patents, one includes nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer. This invention relates to newly discovered nucleic acid molecules and proteins associated with ovarian cancer. It provides compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers. Another significant patent involves compositions, kits, and methods for the identification, assessment, prevention, and therapy of breast cancer. This invention also relates to nucleic acid molecules and proteins associated with breast cancer, offering similar compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers.
Career Highlights
Wilson O Endege has worked with prominent companies in the pharmaceutical industry, including Bayer Corporation and Millennium Pharmaceuticals Limited. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Some of his notable coworkers include Donna M Ford and John E Monahan, who have collaborated with him on various projects.
Conclusion
Wilson O Endege's contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the field positively.